Researcher
Beppe Floris
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From29 Oct 2007 → 2 Feb 2011 - Translational Cell & Tissue Research (Division)
Member
From12 May 2004 → Today
Projects
1 - 10 of 20
- Atlas of therapeutic targets in metastatic breast cancer.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The changing HER2 biomarker testing policy: Impact and training for the Belgian pathology laboratoriesFrom12 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- MetLob: A post-mortem tissue donation study dedicated to Metastatic Lobular breast cancerFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Histopathological heterogeneity of metastatic breast cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → 15 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of the tumor microenvironment of breast cancer metastasesFrom11 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- FAT-IBC: Facing adiposity in personalizing treatment of Inflammatory Breast Cancer patients.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Improving immuno-oncology diagnostics by high-dimensional correlation analysis of histopathology and proteomics data in breast cancer samplesFrom4 Sep 2020 → 22 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 169
- Reporting on invasive lobular breast cancer in clinical trials: a systematic review.(2024)
Authors: Karen Van Baelen, Josephine Van Cauwenberge, Beppe Floris, Hans Wildiers, Christine Desmedt
Pages: 23 - Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy.(2023)
Authors: Maxim De Schepper, Ha Linh Nguyen, François Richard, Sophia Leduc, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Beppe Floris, Christine Desmedt
Pages: 186 - 199 - Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases(2023)
Authors: Sophia Leduc, Maxim De Schepper, François Richard, Anirudh Pabba, Kristien Borremans, Gitte Zels, Karen Van Baelen, Ha Linh Nguyen, Tatjana Geukens, Baki Topal, et al.
- High-grade HER2-positive mucoepidermoid carcinoma of the breast: a case report and review of the literature(2023)
Authors: Esther Hauben, Caroline Weltens, Ines Nevelsteen, Beppe Floris
- Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer(2023)
Authors: Yentl Lambrechts, Abhishek Garg, Beppe Floris, Patrick Neven, Ines Nevelsteen, François Richard, Annouschka Laenen, Christine Desmedt, Hans Wildiers, Sigrid Hatse
Pages: 270 - 279 - Innovative translational research approaches for unmet clinical needs in breast cancer(2023)
Authors: Tatjana Geukens, Christine Desmedt, Hans Wildiers, Beppe Floris
- Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features(2023)
Authors: Beppe Floris, Kristel Van Calsteren, Patrick Neven, Sileny Han, Daniela Annibali, Diether Lambrechts, Liesbeth Lenaerts, Frédéric Amant
Pages: 3729 - 3743 - HISTOPATHOLOGICAL HETEROGENEITY OF PRIMARY AND METASTATIC BREAST CANCER(2023)
Authors: Maxim De Schepper, Christine Desmedt, Beppe Floris
- Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer(2023)
Authors: Karen Van Baelen, Ha Linh Nguyen, François Richard, Maxim De Schepper, Tatjana Geukens, Sileny Han, Thaïs Baert, Hans Wildiers, Ann Smeets, Ines Nevelsteen, et al.
- Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors(2023)
Authors: Yentl Lambrechts, Sigrid Hatse, François Richard, Bram Boeckx, Beppe Floris, Christine Desmedt, Patrick Neven, Diether Lambrechts, Hans Wildiers